116
Views
2
CrossRef citations to date
0
Altmetric
Original Research

Carmustine enhances the anticancer activity of selenite in androgen-independent prostate cancer cells

, &
Pages 383-395 | Published online: 09 Nov 2012

References

  • JinJKDayyaniFGallickGESteps in prostate cancer progression that lead to bone metastasisInt J Cancer2011128112545256121365645
  • American Cancer SocietyCancer Facts and Figures 2012Atlanta, GAAmerican Cancer Society2012
  • MimeaultMJohanssonSLVankatramanGCombined targeting of epidermal growth factor receptor and hedgehog signaling by gefitinib and cyclopamine cooperatively improves the cytotoxic effects of docetaxel on metastatic prostate cancer cellsMol Cancer Ther20076396797817363490
  • ValkoMLeibfritzDMoncolJCroninMTMazurMTelserJFree radicals and antioxidants in normal physiological functions and human diseaseThe international journal of biochemistry and cell biology20073914484
  • DasUA radical approach to cancerMed Sci Monit200284RA79RA9211951081
  • PelicanoHCarneyDHuangPROS stress in cancer cells and therapeutic implicationsDrug Resist Updat2004729711015158766
  • SunYFree radicals, antioxidant enzymes, and carcinogenesisFree Radic Biol Med1990865835992193855
  • RamoutarRRBrumaghimJLAntioxidant and anticancer properties and mechanisms of inorganic selenium, oxo-sulfur, and oxo-selenium compoundsCell Biochem Biophys201058112320632128
  • LippmanSMKleinEAGoodmanPJEffect of selenium and vitamin E on risk of prostate cancer and other cancers: the Selenium and Vitamin E Cancer Prevention Trial (SELECT)JAMA20093011395119066370
  • ZengHCombsGFJrSelenium as an anticancer nutrient: roles in cell proliferation and tumor cell invasionJ Nutr Biochem20081911717588734
  • MueckeRSchomburgLBuentzelJKistersKMickeOSelenium or no selenium – that is the question in tumor patients: a new controversyIntegr Cancer Ther20109213614120462857
  • Institute of Medicine Panel of Dietary antioxidants and related compoundsDietary reference intakes for vitamin C, Vitamin E, Selenium, and Carotenoids A report of the panel on Dietary Antioxidants and Related CompoundsFood and Nutrition Board, Institute of MedicineWashington, District of ColumbiaNational Academy Press2000
  • XiangNZhaoRZhongWSodium selenite induces apoptosis by generation of superoxide via the mitochondrial-dependent pathway in human prostate cancer cellsCancer Chemotherapy and Pharmacology200963235136218379781
  • HusbeckBPeehlDMKnoxSJRedox modulation of human prostate carcinoma cells by selenite increases radiation-induced cell killingFree Radic Biol Med2005381505715589371
  • KandasNORandolphCBoslandMCDifferential effects of selenium on benign and malignant prostate epithelial cells: stimulation of LNCaP cell growth by noncytotoxic, low selenite concentrationsNutr Cancer200961225126419235042
  • MorrisonDGMedinaDDistinguishing features of cytotoxic and pharmacological effects of selenite in murine mammary epithelial cells in vitroToxicol Lett19884433073143217946
  • ShenHMYangCFDingWXLiuJOngCNSuperoxide radical-initiated apoptotic signalling pathway in selenite-treated HepG(2) cells: mitochondria serve as the main targetFree Radic Biol Med200130192111134891
  • KimYSJhonDYLeeKYInvolvement of ROS and JNK1 in selenite-induced apoptosis in Chang liver cellsExp Mol Med200436215716415150444
  • GalloMAragnoMGattoVProtective effect of dehydroepiandrosterone against lipid peroxidation in a human liver cell lineEur J Endocrinol19991411353910407220
  • CorcoranNMNajdovskaMCostelloAJInorganic selenium retards progression of experimental hormone refractory prostate cancerJ Urol20041712 Pt 190791014713851
  • TianJNingSKnoxSJSodium selenite radiosensitizes hormone-refractory prostate cancer xenograft tumors but not intestinal crypt cells in vivoInt J Radiat Oncol Biol Phys201078123023620615620
  • LiGXLeeHJWangZSuperior in vivo inhibitory efficacy of methylseleninic acid against human prostate cancer over selenomethionine or seleniteCarcinogenesis20082951005101218310093
  • DavisMRKassahunKJochheimCMBrandtKMBaillieTAGlutathione and N-acetylcysteine conjugates of 2-chloroethyl isocyanate. Identification as metabolites of N,N′-bis(2-chloroethyl)-N-nitrosourea in the rat and inhibitory properties toward glutathione reductase in vitroChem Res Toxicol1993633763838318660
  • ThamilselvanVMenonMThamilselvanSAnticancer efficacy of deguelin in human prostate cancer cells targeting glycogen synthase kinase-3 beta/beta-catenin pathwayInt J Cancer2011129122916292721472727
  • RashedTMenonMThamilselvanSMolecular mechanism of oxalate-induced free radical production and glutathione redox imbalance in renal epithelial cells: effect of antioxidantsAm J Nephrol200424555756815539792
  • ThamilselvanVMenonMThamilselvanSOxalate-induced activation of PKC-alpha and -delta regulates NADPH oxidase-mediated oxidative injury in renal tubular epithelial cellsAm J Physiol Renal Physiol20092975F1399F141019692488
  • ShackSMillerALiuLPrasannaPThibaultASamidDVulnerability of multidrug-resistant tumor cells to the aromatic fatty acids phenylacetate and phenylbutyrateClin Cancer Res1996258658729816242
  • BatistGKatkiAGKleckerRWJrMyersCESelenium-induced cytotoxicity of human leukemia cells: interaction with reduced glutathioneCancer Res19864611548254853756896
  • JiangCHuHMalewiczBWangZLuJSelenite-induced p53 Ser-15 phosphorylation and caspase-mediated apoptosis in LNCaP human prostate cancer cellsMol Cancer Ther20043787788415252149
  • MenterDGSabichiALLippmanSMSelenium effects on prostate cell growthCancer Epidemiol Biomarkers Prev20009111171118211097224
  • ShenHMYangCFOngCNSodium selenite-induced oxidative stress and apoptosis in human hepatoma HepG2 cellsInt J Cancer199981582082810328239
  • ZhongWYanTWebberMMOberleyTDAlteration of cellular phenotype and responses to oxidative stress by manganese superoxide dismutase and a superoxide dismutase mimic in RWPE-2 human prostate adenocarcinoma cellsAntioxid Redox Signal20046351352215130278
  • SekoYSaitoYKitaharaJImuraNActive oxygen generation by the reaction of selenite with reduced glutathione in vitroWendelASelenium in Biology and MedicineBerlin, GermanySpringer-Verlag1989
  • CombsGFJrGrayWPChemopreventive agents: seleniumPharmacol Ther19987931791929776375
  • HusbeckBNonnLPeehlDMKnoxSJTumor-selective killing by selenite in patient-matched pairs of normal and malignant prostate cellsProstate200666221822516173037
  • ShenHYangCLiuJOngCDual role of glutathione in selenite-induced oxidative stress and apoptosis in human hepatoma cellsFree Radic Biol Med20002871115112410832073
  • ZhangKMackPWongKPGlutathione-related mechanisms in cellular resistance to anticancer drugsInt J Oncol19981248718829499449
  • Ali-OsmanFSteinDERenwickAGlutathione content and glutathione-S-transferase expression in 1,3-bis(2-chloroethyl)-1-nitrosourea-resistant human malignant astrocytoma cell linesCancer Res19905021697669802208164
  • Ali-OsmanFAntounGWangHRajagopalSGagucasEButhionine sulfoximine induction of gamma-L-glutamyl-L-cysteine synthetase gene expression, kinetics of glutathione depletion and resynthesis, and modulation of carmustine-induced DNA-DNA cross-linking and cytotoxicity in human glioma cellsMol Pharmacol1996496101210208649339
  • LeBoeufRAHoekstraWGAdaptive changes in hepatic glutathione metabolism in response to excess selenium in ratsJ Nutr198311348458546131951
  • LeBoeufRALaishesBAHoekstraWGEffects of selenium on cell proliferation in rat liver and mammalian cells as indicated by cytokinetic and biochemical analysisCancer Res19854511 Pt 1549655044053023
  • BostwickDGAlexanderEESinghRAntioxidant enzyme expression and reactive oxygen species damage in prostatic intraepithelial neoplasia and cancerCancer200089112313410897009
  • LimHWHongSJinWUp-regulation of defense enzymes is responsible for low reactive oxygen species in malignant prostate cancer cellsExp Mol Med200537549750616264276
  • KrajewskiSChattenJHanadaMReedJCImmunohistochemical analysis of the Bcl-2 oncoprotein in human neuroblastomas. Comparisons with tumor cell differentiation and N-Myc proteinLab Invest199572142547837790
  • McDonnellTJTroncosoPBrisbaySMExpression of the protooncogene bcl-2 in the prostate and its association with emergence of androgen-independent prostate cancerCancer Res19925224694069441458483
  • MiyakeHTolcherAGleaveMEAntisense Bcl-2 oligodeoxynucleotides inhibit progression to androgen-independence after castration in the Shionogi tumor modelCancer Res199959164030403410463603
  • GleaveMEMiayakeHGoldieJNelsonCTolcherATargeting bcl-2 gene to delay androgen-independent progression and enhance chemosensitivity in prostate cancer using antisense bcl-2 oligodeoxynucleotidesUrology199954Suppl 6A364610606283
  • RaffoAJPerlmanHChenMWDayMLStreitmanJSButtyanROverexpression of bcl-2 protects prostate cancer cells from apoptosis in vitro and confers resistance to androgen depletion in vivoCancer Res19955519443844457671257
  • MouldingDAGilesRVSpillerDGWhiteMRTiddDMEdwardsSWApoptosis is rapidly triggered by antisense depletion of MCL-1 in differentiating U937 cellsBlood20009651756176310961874
  • ZhangBGojoIFentonRGMyeloid cell factor-1 is a critical survival factor for multiple myelomaBlood20029961885189311877256
  • ToyokuniSOkamotoKYodoiJHiaiHPersistent oxidative stress in cancerFEBS Lett19953581137821417
  • ToyokuniSSagripantiJLHitchinsVMCytotoxic and mutagenic effects of ferric nitrilotriacetate on L5178Y mouse lymphoma cellsCancer Lett19958821571627874688
  • BenekeRGeisenCZevnikBDNA excision repair and DNA damage-induced apoptosis are linked to poly(ADP-ribosyl)ation but have different requirements for p53Mol Cell Biol200020186695670310958667